Cargando…
Inhibition of epidermal growth factor receptor suppresses parathyroid hormone‐related protein expression in tumours and ameliorates cancer‐associated cachexia
BACKGROUND: Lung cancer is the primary cause of cancer deaths worldwide. Activation of epidermal growth factor receptor (EGFR) leads to lung cancer progression and poor prognosis while involuntary weight loss remains a major problem. Tumour‐derived parathyroid hormone‐related protein (PTHrP) emerged...
Autores principales: | Weber, Bahar Zehra Camurdanoglu, Agca, Samet, Domaniku, Aylin, Bilgic, Sevval Nur, Arabaci, Dilsad H., Kir, Serkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178359/ https://www.ncbi.nlm.nih.gov/pubmed/35373517 http://dx.doi.org/10.1002/jcsm.12985 |
Ejemplares similares
-
Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia
por: Weber, Bahar Zehra Camurdanoglu, et al.
Publicado: (2022) -
Parathyroid hormone related protein (PTHrP) in patients with pancreatic carcinoma and overt signs of disease progression and host tissue wasting
por: Iresjö, Britt-Marie, et al.
Publicado: (2023) -
A Case of Lymphoma Simulating Primary Sternal Tumour
por: Sahin, Atalay, et al.
Publicado: (2014) -
Amelioration of muscle wasting by gintonin in cancer cachexia
por: Wijaya, Yoseph Toni, et al.
Publicado: (2021) -
Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL‐6 and tumour‐derived extracellular vesicles
por: Fan, Meng, et al.
Publicado: (2022)